COO - Cooper Companies, Inc Stock Analysis

Cooper Companies, Inc (COO) is a publicly traded company listed on the NASD. It operates in the Medical Instruments & Supplies industry, part of the broader Healthcare sector. The company has a market capitalization of 14.34B, generates annual revenue of 4.05B, and reports net income of 407.80M. As of the latest data, the stock is trading at 72.13 USD.

From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. This stock does not currently pay a dividend. The stock has average market volatility, aligning with general market movement.

Analyst recommendation stands at Hold (3.76), indicating current market sentiment. Institutional ownership is reported at 104.16%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -29.28%, trading within a 52-week range of 61.78 - 106.63.

COO - Cooper Companies, Inc

72.13
Analyst Consensus
Hold 3.76
COO – Analyst Rating Summary
Analyst Pie Chart
  • Strong Buy: 5
  • Buy: 10
  • Hold: 9
  • Sell: 1
  • Strong Sell: 0
  • Total Analysts:  25

Last update: 2025-11-16 04:54:02
Index: S&P 500 P/E: 35.51 EPS (ttm): 2.03 Insider Own: 0.63% Shs Outstand: 198.80M Perf Week: 2.90%
Market Cap: 14.34B Forward P/E: 16.37 EPS next Y: 4.41 Insider Trans: 1.46% Shs Float: 197.56M Perf Month: 0.80%
Income(ttm): 407.80M PEG: 3.82 EPS next Q: 1.11 Inst Own: 104.16% Short Float: 3.27% Perf Quarter: -1.90%
Revenue(ttm): 4.05B P/S: 3.54 EPS this Y: 10.99% Inst Trans: 3.82% Short Ratio: 2.34 Perf Half Y: -13.01%
Book/sh: 42.02 P/B: 1.72 EPS next Y: 7.61% ROA: 3.33% Short Interest: 6.45M Perf Year: -29.28%
Cash/sh: 0.63 P/C: 114.81 EPS next 5Y: 9.29% ROE: 5.01% 52W Range: 61.78 - 106.63 Perf YTD: -21.54%
Dividend Est.: - P/FCF: 34.81 EPS past 3/5Y: -49.03% -3.45% ROIC: 3.78% 52W High: 106.63 -32.35% Beta: 1.05
Dividend TTM: - Quick Ratio: 1.24 Sales past 3/5Y: 10.05% 7.98% Gross Margin: 62.03% 52W Low: 61.78 16.76% Perf 5Y: -17.97%
Dividend Ex-Date: Jul 26, 2023 Current Ratio: 2.12 EPS Y/Y TTM: 12.94% Oper. Margin: 18.31% RSI (14): 56.04 Volatility: 2.10% 2.32%
Employees: 16000 Debt/Eq: 0.30 Sales Y/Y TTM: 6.35% Profit Margin: 10.08% Recom: 2.14 Target Price: 81.88
Option/Short: Yes / Yes LT Debt/Eq: 0.29 EPS Q/Q: -5.82% Payout: 0.00% Rel Volume: 0.94 Prev Close: 71.75
Sales Surprise: -0.34% EPS Surprise: 3.23% Sales Q/Q: 5.73% Earnings: Dec 04 AMC Avg Volume: 2.76M Price: 72.13
SMA20: 0.71% SMA50: 3.48% SMA200: -5.17% Undervalued: 13.52%
Volume: 2,598,974 Change: 0.53%
Graham's revised valuation formula
Discounted cash flow (DCF) model
Margin of safety

About Cooper Companies, Inc

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.

Copyright © 2024 - 2025 www.stocks-expert.com All Rights Reserved.